Porton Pharma Solutions's quarterly market cap
declined
from Sep. 2023 (¥15,444 Mil) to Dec. 2023 (¥13,735 Mil) and
declined
from Dec. 2023 (¥13,735 Mil) to Mar. 2024 (¥9,774 Mil).
Porton Pharma Solutions's annual market cap
declined
from Dec. 2021 (¥48,697 Mil) to Dec. 2022 (¥22,305 Mil) and
declined
from Dec. 2022 (¥22,305 Mil) to Dec. 2023 (¥13,735 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Porton Pharma Solutions's Enterprise Value for Today is ¥8,509 Mil.
Porton Pharma Solutions Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Porton Pharma Solutions's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Porton Pharma Solutions's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Porton Pharma Solutions's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Porton Pharma Solutions's Market Cap distribution charts can be found below:
* The bar in red indicates where Porton Pharma Solutions's Market Cap falls into.
Porton Pharma Solutions Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Porton Pharma Solutions's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Porton Pharma Solutions (SZSE:300363) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Porton Pharma Solutions Market Cap Related Terms
Thank you for viewing the detailed overview of Porton Pharma Solutions's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Porton Pharma Solutions (SZSE:300363) Business Description
Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300363 has been successfully added to your 